Richard J. Macisaac

Fitzroy, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 236 publications

Treatment-Induced Neuropathy of Diabetes: Focus on Autonomic Neuropathy.

Treatment-Induced Neuropathy of Diabetes: Focus on Autonomic Neuropathy.

Journal: Cureus

Published: June 28, 2026

Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy.

Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy.

Journal: Journal of cardiovascular development and disease

Published: June 01, 2026

β-Cell Function and Diabetes Outcomes 1 Year After Stopping Oral Baricitinib Immunotherapy for Type 1 Diabetes.

β-Cell Function and Diabetes Outcomes 1 Year After Stopping Oral Baricitinib Immunotherapy for Type 1 Diabetes.

Journal: Diabetes care

Published: May 06, 2026

The Emerging Role of Glucagon-like Peptide 1 (GLP-1)-Based Medications in the Treatment of Heart Failure, with a Focus on Heart Failure with Preserved or Mildly Reduced Ejection Fraction.

The Emerging Role of Glucagon-like Peptide 1 (GLP-1)-Based Medications in the Treatment of Heart Failure, with a Focus on Heart Failure with Preserved or Mildly Reduced Ejection Fraction.

Journal: Medicina (Kaunas, Lithuania)

Published: March 27, 2026

The effect of intraoperative dexamethasone on glycaemic responses in people with diabetes mellitus: a preplanned analysis of the Perioperative ADministration of Dexamethasone and Infection trial.

The effect of intraoperative dexamethasone on glycaemic responses in people with diabetes mellitus: a preplanned analysis of the Perioperative ADministration of Dexamethasone and Infection trial.

Journal: British journal of anaesthesia

Published: February 19, 2026

Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.

Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.

Journal: Diabetes technology & therapeutics

Published: February 13, 2026

Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.

Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring.

Journal: Diabetes technology & therapeutics

Published: February 13, 2026

Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial.

Multi-Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial.

Journal: Diabetes, obesity & metabolism

Published: February 06, 2026

The impact of automated insulin delivery on glucose management in people with diabetes and advanced chronic kidney disease.

The impact of automated insulin delivery on glucose management in people with diabetes and advanced chronic kidney disease.

Journal: Diabetologia

Published: January 09, 2026

Albuminuria testing rates in people with diabetes, Victoria, 2022-2024: analysis of a pathology dataset.

Albuminuria testing rates in people with diabetes, Victoria, 2022-2024: analysis of a pathology dataset.

Journal: Internal medicine journal

Published: November 24, 2025

Automated Insulin Delivery Beyond Glycemic Outcomes: Endpoints and Evidence.

Automated Insulin Delivery Beyond Glycemic Outcomes: Endpoints and Evidence.

Journal: Diabetes technology & therapeutics

Published: November 20, 2025

Enhancing nationwide awareness of cholesterol treatment in type 1 diabetes (ENACT-T1D): an Australian multi-centre survey of patients and clinicians.

Enhancing nationwide awareness of cholesterol treatment in type 1 diabetes (ENACT-T1D): an Australian multi-centre survey of patients and clinicians.

Journal: Internal medicine journal

Published: October 02, 2025

Showing 1-12 of 236

Last Updated: 09/26/2026